Iambic Therapeutics
Series CIambic Therapeutics is a privately held company based in United States, founded in 2019. The latest disclosed round is Series C ($100m), dated Nov 06, 2025. Institutional investors on record include Sequoia Capital.
United States · EST 2019
What is Iambic Therapeutics?
Iambic Therapeutics is a privately held company based in United States, founded in 2019. The latest disclosed round is Series C ($100m), dated Nov 06, 2025. Institutional investors on record include Sequoia Capital. Provider of AI-driven drug discovery platform for the treatment of cancer. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Iambic Therapeutics?
Who invested in Iambic Therapeutics?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Sequoia Capital | Series C | $100m | Nov 06, 2025 |
What do founders ask about Iambic Therapeutics?
What is Iambic Therapeutics?
Iambic Therapeutics is a privately held company based in United States, founded in 2019. The latest disclosed round is Series C ($100m), dated Nov 06, 2025. Institutional investors on record include Sequoia Capital. Provider of AI-driven drug discovery platform for the treatment of cancer. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Iambic Therapeutics's last funding round?
Iambic Therapeutics's latest disclosed round is Series C at $100m (Nov 06, 2025).
Who invested in Iambic Therapeutics?
Iambic Therapeutics has 1 institutional investors on this page, including Sequoia Capital.
How does CrackTheDeck cover Iambic Therapeutics?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Iambic Therapeutics card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.